Kintara Therapeutics Inc (KTRA)

[jssdmm]

The Renshaw presentation for DMPI was interesting. Listen to it?

They will certainly be raising money next year. That's a fact.

But their unique ability to become the new standard for chemotherapy for some 70% of patients in GBM as well as Non-Small Cell Lung Cancer and Ovarian cancer shows their belief in the efficacy to be intact. It may take a while longer, but the path to success is there. So timing for investors is key.

Interim results will be made available for the phase 2 trials. They both are more highly targeted to the optimal patients, plus treatment will be utilized earlier in the cycle when efficacy may be more easily obtained.

Two new members of the team were announced, too. I like this.

Price is an entirely different conversation. I can see it dropping as you said. I will hold and buy in more if it does.